In the field of radiotherapy (RT), the issues of total dose, fractionation, and overall treatment
time for non-small cell lung cancer (NSCLC) have been extensively investigated. There is …

Radical radiotherapy plays a major role in the treatment of non-small cell lung cancer
(NSCLC) due to the fact that many patients are medically or surgically inoperable. Advances …

Purpose A series of radiobiological models were developed to study tumor control
probability (TCP) for stereotactic body radiation therapy (SBRT) of early-stage non-small cell …

Purpose To examine the impact of stereotactic body radiation therapy (SBRT) dose on
outcomes in early-stage non-small cell lung cancer in a large single-institution series …

The origin of fractionated radiotherapy dates back to observations by French investigators
Regaud and Coutard, among others, during the 1920s and 1930s [1]. Before this time, there …

Introduction Modified fractionation radiotherapy (RT), delivering multiple fractions per day or
shortening the overall treatment time, improves overall survival for non-small-cell lung …

PURPOSE: To review the published clinical data on non-small cell lung cancer treated with
radical radiotherapy to confirm a dose–response relationship as a basis for further dose …

After target volume definition, irradiation dose and fractionation are the major outcome-
determining factors of radiation therapy. Randomized trials asking the question of the …

Purpose In lung cancer, randomized trials assessing hyperfractionated or accelerated
radiotherapy seem to yield conflicting results regarding the effects on overall (OS) or …

Purpose Treatment regimens for locally advanced non-small cell lung cancer (NSCLC) give
suboptimal clinical outcomes. Technological advancements such as radiation therapy, the …